Condition: Diabetes Mellitus, Type 1 · Diabetes Mellitus, Type 2 · Sponsor: German Diabetes Center
The aim of the prospective observational GDC-Study in patients with newly diagnosed diabetes mellitus aged 18-69 years at inclusion into the study is to characterize in detail the clinical, metabolical and immunological phenotype and monitor the progression of the disease and to compare the phenotype to glucose tolerant humans of similar age, body mass and sex distribution.
This description comes directly from the study's public registry record.
Robert Wagner, Prof., MD · +49-211-3382 · robert.wagner@ddz.de
Petra Heidkamp · +49-211-3382 · studienzentrum@ddz.de
Always discuss trial participation with your own doctor first.
| German Diabetes Center | Düsseldorf, North Rhine-Westphalia, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01055093